About
The U.S. Military HIV Research Program (MHRP) is dedicated to HIV vaccine development, prevention, disease surveillance and care and treatment for HIV.
HIV-1 continues to pose a significant and persistent threat to the U.S. military and allied forces both in terms of readiness and force protection. The brisk pace of deployments to locations throughout the world requires the MHRP to develop products and capabilities with an international scope.
This program builds on the strength of the U.S. military medical research community, and addresses specific HIV research requirements to meet its mission: prevention of HIV-1 disease in the active force and, by extension, the global community at risk of infection.
Our directive includes:
- defining the global HIV epidemic by traditional and molecular epidemiologic methods
- developing diagnostic and immunologic assays critical for vaccine development
- designing, evaluating and testing vaccine products from pre-clinical through Phase III efficacy trials
- conducting translational research for the care and treatment of HIV-infected individuals
The Program is centered at the Division of Retrovirology, Walter Reed Army Institute of Research (WRAIR), U.S. Army Medical Research and Materiel Command (USAMRMC).
MHRP is closely partnered with the not-for-profit Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF). Partnerships between WRAIR and HJF support research activities in Thailand, Kenya, Uganda, Tanzania, Peru, Cairo, Indonesia, Nigeria and other international locations.
Program personnel include active-duty service members of the U.S. Army, Navy, Air Force and Public Health Service, as well as federal civilians and employees of HJF and other international research groups.